Evidence map›Paper›PMID 40447965›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Narrative medicine in patients with cancer during intravenous antiblastic therapy: a qualitative study.

Valentina Micheluzzi, Francesco Burrai, Antonella Delogu, Maria Giovanna Schintu, Teresa Pira, Claudio Sini

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The healing promise of narrative medicine in cancer care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valentina MicheluzziDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy. vmicheluzzi@uniss.it.ORCID http://orcid.org/0000-0001-5780-6775
Francesco BurraiDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
Antonella DeloguMedical Oncology, San Giovanni Paolo II Hospital, ASL of Gallura, Olbia, Italy.
Maria Giovanna SchintuMedical Oncology, San Giovanni Paolo II Hospital, ASL of Gallura, Olbia, Italy.
Teresa PiraMedical Oncology, San Giovanni Paolo II Hospital, ASL of Gallura, Olbia, Italy.
Claudio SiniMedical Oncology, San Giovanni Paolo II Hospital, ASL of Gallura, Olbia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with cancer during antineoplastic infusion therapy live an existential period characterized by experiences of profound psychological, physical, social, and spiritual changes. PURPOSE: To explore the patients' experiences during antineoplastic therapy using narrative medicine.

methodsA qualitative descriptive study, utilizing content analysis, was embedded within a randomized controlled three-arm trial. The study focused on analyzing their writings expressed through narrative medicine. The narrative medicine intervention was administered immediately after the start of antineoplastic therapy. While seated in outpatient chairs, and after the infusion began, a trained nurse provided participants with a pen and notepad, explaining that they could use the next 30 min to freely write about their subjective experiences during the infusion of antineoplastic therapy.

resultsData from twenty-four interviews reached saturation. Content analysis identified five main categories and twelve subcategories: cognitive processes (positive thoughts, negative thoughts, memory, attention, imagination, learning); emotive processes (primary negative emotions, secondary negative emotions, primary positive emotions, secondary positive emotions); behavioral processes (positive behaviors); social processes (social relationships with healthcare professionals, social relationships with family members, social relationships with caregivers); and perceptual processes (adverse effects of antineoplastic therapy).

conclusionsOur finding revealed the complex, multidimensional experiences of patients undergoing antineoplastic therapy. Narrative medicine facilitated a profound, multidimensional exploration of their experience of receiving antineoplastic therapy, addressing psychological, physical, social, and spiritual aspects.

Indexed as

Antineoplastic AgentsNarrative MedicineNeoplasmsAdultAgedEmotionsFemaleHumansInfusions, IntravenousInterviews as TopicMaleMiddle AgedQualitative ResearchAntineoplastic AgentsAntineoplastic infusion therapyCancerContent analysisNarrative medicineQualitative research

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.